Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYMyovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine FibroidsPREV STORYCodiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters’ Option